Mayinglong Pharmaceutical Group Co Ltd (600993)

Shanghai

Currency in CNY

23.25

-0.55(-2.31%)

Closed·10/07

Fair Value

Unlock Value

Day's Range

23.12

23.77

52 wk Range

21.22

30.18

600993 Income Statement

Assess the Mayinglong Pharm income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 600993 net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

3,385.06

3,532.38

3,136.75

3,728.02

3,866.61

Total Revenues Growth

aa.aa

+21.26%

+4.35%

-11.2%

+18.85%

+3.72%

Cost Of Revenues

aa.aa

2,018.78

2,038.18

1,829.48

1,997.03

1,965.87

Gross Profit

aa.aa

1,366.28

1,494.2

1,307.26

1,730.99

1,900.73

Gross Profit Growth

aa.aa

+23.77%

+9.36%

-12.51%

+32.41%

+9.81%

Gross Profit Margin %

aa.aa

40.36%

42.3%

41.68%

46.43%

49.16%

Other Operating Expenses, Total

aa.aa

912.9

1,000.04

922.54

1,143.87

1,256.02

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+20.94%	+9.54%	-7.75%	+23.99%	+9.8%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	66.73	77.89	69.01	66.69	78.11
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	821.11	895.99	829.14	1,059.58	1,152.55
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	25.06	26.16	24.39	17.6	25.35

Operating Income

aa.aa

453.38

494.16

384.73

587.12

644.71

Operating Income Growth

aa.aa

+29.88%

+9%

-22.15%

+52.61%

+9.81%

EBIT Margin %

aa.aa

13.39%

13.99%

12.27%

15.75%

16.67%

Net Interest Expenses

aa.aa

68.64

87.24

134.65

71.51

62.67

Net Interest Expenses Growth

aa.aa

+193.14%

+27.08%

+54.35%

-46.89%

-12.35%

Interest Expense, Total

aa.aa

-10.21

-11.69

-16.85

-7.38

Interest And Investment Income

aa.aa

78.85

98.92

151.5

78.88

70.05

Other Non Operating Expenses, Total

aa.aa

-5.13

-6.18

-3.72

0.93

2.3

EBT, Excl. Unusual Items

aa.aa

516.89

575.22

515.65

659.55

709.68

Gain (Loss) On Sale Of Assets

aa.aa

-0.5

-0.01

1.12

-0.14

-5.21

Other Unusual Items, Total

aa.aa

14.13

21.99

8.28

4.71

12.58

EBT, Incl. Unusual Items

aa.aa

548.16

559.14

524.7

657.55

709

EBT, Incl. Unusual Items Growth

aa.aa

+10.14%

+2%

-6.16%

+25.32%

+7.82%

EBT, Incl. Unusual Items Margin

aa.aa

16.19%

15.83%

16.73%

17.64%

18.34%

Income Tax Expense

aa.aa

74.11

79.78

72.86

109.26

103.29

Net Income to Company

aa.aa

474.05

479.35

451.84

548.3

605.71

Minority Interest

aa.aa

-9.46

-0.78

-8.59

-20.2

-24.22

Net Income

aa.aa

464.59

478.57

443.25

528.09

581.49

Net Income Growth

aa.aa

+10.87%

+3.01%

-7.38%

+19.14%

+10.11%

Net Income Margin %

aa.aa

13.72%

13.55%

14.13%

14.17%

15.04%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

464.59

478.57

443.25

528.09

581.49

Basic EPS - Continuing Operations

aa.aa

1.08

1.11

1.03

1.23

1.35

Basic EPS - Continuing Operations Growth

aa.aa

+11.34%

+2.78%

-7.21%

+19.42%

+9.76%

Diluted EPS - Continuing Operations

aa.aa

1.08

1.11

1.03

1.23

1.35

Diluted EPS - Continuing Operations Growth

aa.aa

+11.34%

+2.78%

-7.21%

+19.42%

+9.76%

Basic Weighted Average Shares Outstanding

aa.aa

430.18

431.15

430.34

429.34

430.74

Diluted Weighted Average Shares Outstanding

aa.aa

430.18

431.15

430.34

429.34

430.74

Dividend Per Share

aa.aa

0.35

0.4

0.62

0.7

Dividend Per Share Growth

aa.aa

+16.67%

+14.29%

+55%

+12.9%

EBITDA

aa.aa

495.12

541.14

434.2

638.41

703.43

EBITDA Growth

aa.aa

+28.83%

+9.29%

-19.76%

+47.03%

+10.19%

EBITDA Margin %

aa.aa

14.63%

15.32%

13.84%

17.12%

18.19%

EBIT

aa.aa

453.38

494.16

384.73

587.12

644.71

* In Millions of CNY (except for per share items)

FAQ

What was Mayinglong Pharm’s revenue at year end?

At the end of the last reported fiscal year, Mayinglong Pharm (600993) recorded total revenue of 3,866.61 million CNY.

How much revenue did Mayinglong Pharm report in the most recent quarter?

In its most recent quarterly earnings report, Mayinglong Pharm posted revenue of 1,012.36 million CNY.

What was Mayinglong Pharm’s net income for the year?

For the full year, Mayinglong Pharm reported net income of 581.49 million CNY.

How much net income did Mayinglong Pharm post in the last quarter?

In the most recent quarter, Mayinglong Pharm (600993) posted net income of 212.59 million CNY.

What was Mayinglong Pharm’s gross profit for the year?

Gross profit for the year was reported at 1,900.73 million CNY.

How much gross profit did Mayinglong Pharm generate last quarter?

Mayinglong Pharm recorded gross profit of 487.98 million CNY in its latest quarterly report.

What was Mayinglong Pharm’s annual operating income?

For the full year, Mayinglong Pharm (600993) reported operating income of 644.71 million CNY.

What was Mayinglong Pharm’s operating income last quarter?

Quarterly operating income was 244.73 million CNY.

What was Mayinglong Pharm’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 259.41 million CNY.

What was the quarter-over-quarter change in EBITDA for Mayinglong Pharm?

EBITDA changed by 162.66% million CNY compared to the last quarter.

What is Mayinglong Pharm’s most recent gross profit margin?

The latest reported gross profit margin for Mayinglong Pharm (600993) is 48.20% million CNY.

What is Mayinglong Pharm’s most recent net income margin?

Net income margin based on recent financials is 21.00% million CNY.

What is Mayinglong Pharm’s most recent EBIT margin?

Mayinglong Pharm reported an EBIT margin of 24.17% million CNY based on current figures.

How did Mayinglong Pharm’s revenue change compared to the previous quarter?

Revenue changed by -1.65% million CNY compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Mayinglong Pharm?

In the latest quarter, gross profit changed by -3.95% million CNY from the previous quarter.

S&P/TSX

35,305.31

+104.86

+0.30%

S&P/TSX 60

2,082.89

+9.21

+0.44%

US 30

52,688.30

+200.9

+0.38%

US 500

7,579.10

+35.6

+0.47%

S&P 500 VIX

15.03

-0.81

-5.11%

DAX

25,067.09

-51.18

-0.20%

Dollar Index

100.76

+0.070

+0.07%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	59.10	-0.51%	12.93M
Toronto Dominion Bank	170.86	+0.69%	12.75M
Bank of Nova Scotia	124.14	+1.84%	4.29M
Suncor Energy	83.82	+1.02%	4.12M
Canadian Imperial Bank	166.97	+2.10%	2.73M
Bank of Montreal	253.39	+1.11%	2.42M
RBC	298.81	+1.00%	2.27M

Name	Last	Chg. %	Vol.
PeakBirch Logic	0.030	+500.00%	1.32K
Pharmadrug	0.01	+200.00%	100.00K
Irwin Naturals	0.30	+150.00%	3.24K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Red Lake Gold	0.0100	+100.00%	20.00K
Pharmadrug	0.0100	+100.00%	100.00K
Vencanna Ventures	0.0100	+100.00%	194.00K

Name	Last	Chg. %	Vol.
Vertiqal Studios	0.01	-100.00%	40.00K
Vertiqal Studios	0.01	-100.00%	40.00K
Biosenta Inc	0.010	-77.78%	6.00K
Digital Asset Tech	0.01	-66.67%	5.89K
Armada Mercantile Ltd	0.165	-59.76%	1.50K
Digicann Ventures	0.005	-50.00%	12.00K
Vice Health Wellness	0.005	-50.00%	2.22M

Trending Stocks

Name	Last	Chg. %	Vol.
Toronto Dominion Bank	170.86	+0.69%	12.75M
TELUS	14.76	0.00%	4.33M
Aritzia	160.05	+7.43%	1.92M
Canadian Imperial Bank	166.97	+2.10%	2.73M
Canadian Natural	59.10	-0.51%	12.93M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaaa	6.77	+61.72%	10.95
Aa Aaaaa A Aaa	94.85	+57.66%	149.54
Aaaaa	5.33	+53.29%	8.17
Aaaaaaaa A A	21.71	+45.91%	31.68
Aa Aaaaaaaaaaaaa	138.34	+45.91%	201.85
Aaaaaa Aaaaa	16.48	+43.80%	23.70
Aaaaa Aaaaaa	5.43	+43.58%	7.80

Name	Last	Upside	Fair Value
Aa Aaaa	6.77	+61.72%	10.95
Aa Aaaaa A Aaa	94.85	+57.66%	149.54
Aaaaa	5.33	+53.29%	8.17
Aaaaaaaa A A	21.71	+45.91%	31.68
Aa Aaaaaaaaaaaaa	138.34	+45.91%	201.85
Aaaaaa Aaaaa	16.48	+43.80%	23.70
Aaaaa Aaaaaa	5.43	+43.58%	7.80

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Mayinglong Pharmaceutical Group Co Ltd (600993)

600993 Income Statement

FAQ

What was Mayinglong Pharm’s revenue at year end?

How much revenue did Mayinglong Pharm report in the most recent quarter?

What was Mayinglong Pharm’s net income for the year?

How much net income did Mayinglong Pharm post in the last quarter?

What was Mayinglong Pharm’s gross profit for the year?

How much gross profit did Mayinglong Pharm generate last quarter?

What was Mayinglong Pharm’s annual operating income?

What was Mayinglong Pharm’s operating income last quarter?

What was Mayinglong Pharm’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Mayinglong Pharm?

What is Mayinglong Pharm’s most recent gross profit margin?

What is Mayinglong Pharm’s most recent net income margin?

What is Mayinglong Pharm’s most recent EBIT margin?

How did Mayinglong Pharm’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Mayinglong Pharm?

Trending Stocks